BeStock  

百健 BIIB

美股市值排名 #574药品制造-综合癌症研究
$248.35 +$4.42 (+1.81%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $248.35 0.00%
开盘$241.28
昨收$243.93
当日区间$240.00 – $250.03
成交量1.00M
市值$36.71B
市盈率(TTM)107.5
股息率–

基本面

最新报告季度:Q2, ended Jun 2026

营收$2.74B+3.4% YoY
营业利润$482.80M-43.3% YoY
净利润$97.50M-84.6% YoY
摊薄每股收益$0.66-84.8% YoY
自由现金流$308.00M+129.3% YoY
经营现金流$448.90M

营收,近8个季度

$2.5BSep '24$2.5BDec '24$2.4BMar '25$2.6BJun '25$2.5BSep '25$2.3BDec '25$2.5BMar '26$2.7BJun '26

净利润,近8个季度

$388.5MSep '24$266.7MDec '24$240.5MMar '25$634.8MJun '25$466.5MSep '25$-48.9MDec '25$319.5MMar '26$97.5MJun '26

各季度摊薄每股收益

2.66Sep '241.83Dec '241.64Mar '254.33Jun '253.17Sep '25-0.33Dec '252.15Mar '260.66Jun '26

各季度自由现金流

$805.6MSep '24$694.6MDec '24$212.2MMar '25$134.3MJun '25$1.2BSep '25$401.7MDec '25$559.3MMar '26$308.0MJun '26

年度营收

$13.4BFY20$11.0BFY21$10.2BFY22$9.8BFY23$9.7BFY24$9.9BFY25

盈利能力与资产负债表

毛利率74.0%
营业利润率19.3%
净利率8.3%
净资产收益率4.6%
资产收益率2.8%
投入资本回报率3.7%
流动比率1.87
负债/资产比率41.3%
现金及投资$1.29B
总负债$8.36B
净现金(净负债)-$7.07B
自由现金流/营收24.8%

营收构成

2026/Q3 季度

按业务线

  • Revenue from anti-CD20 therapeutic programs$497.30M 17.7%
  • SPINRAZA$460.60M 16.4%
  • TYSABRI$437.10M 15.6%
  • Other$424.00M 15.1%
  • VUMERITY$192.00M 6.8%
  • SYFOVRE$191.30M 6.8%
  • SKYCLARYS$178.20M 6.4%
  • AVONEX$156.60M 5.6%
  • Contract manufacturing, royalty and other revenue$149.70M 5.3%
  • BENEPALI$117.30M 4.2%

利润表

项目 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
报告营业总收入 $2.74B $2.48B $9.89B $2.28B $2.53B
营业总收入 $2.74B $2.48B $9.89B $2.28B $2.53B
营业成本 $776.90M $661.00M $2.40B $495.50M $674.40M
毛利润 $1.96B $1.82B $7.49B $1.78B $1.86B
营业费用 $1.48B $1.36B $5.02B $1.40B $1.25B
销售及管理费用 $709.70M $607.30M $2.43B $682.50M $594.80M
研发费用 $529.60M $539.00M $1.78B $509.40M $436.10M
折旧、摊销与折耗 $168.20M $136.50M $515.00M $136.60M $135.70M
-折旧与摊销 $168.20M $136.50M $515.00M $136.60M $135.70M
其他营业费用 $68.80M $74.20M $290.20M $69.90M $87.20M
营业利润 $482.80M $459.80M $2.47B $385.50M $606.50M
非经营性利息净收入(支出) -$57.00M -$29.70M -$142.50M -$30.30M -$35.80M
非经营性利息收入 $25.30M $37.90M $125.00M $37.20M $31.60M
非经营性利息支出 $82.30M $67.60M $267.50M $67.50M $67.40M
其他收入(支出) -$293.40M -$52.40M -$770.00M -$411.20M -$13.40M
证券出售收益 $35.10M $15.80M -$48.30M $2.70M -$14.10M
特殊收益(费用) -$331.50M -$67.10M -$746.40M -$426.60M -$15.10M
-减:重组及并购费用 $167.90M $28.40M $82.20M $11.80M $13.00M
-减:其他特殊支出 $163.60M $38.70M $611.30M $361.90M $2.10M
其他非经营性收入(支出) $3.00M -$1.10M $24.70M $12.70M $15.80M
税前利润 $132.40M $377.70M $1.56B -$56.00M $557.30M
税费 $34.90M $58.20M $263.60M -$7.10M $90.80M
净利润 $97.50M $319.50M $1.29B -$48.90M $466.50M
持续经营利润 $97.50M $319.50M $1.29B -$48.90M $466.50M
归属母公司净利润 $97.50M $319.50M $1.29B -$48.90M $466.50M
归属普通股股东净利润 $97.50M $319.50M $1.29B -$48.90M $466.50M
基本每股收益 $0.66 $2.17 $8.83 -$0.33 $3.18
摊薄每股收益 $0.66 $2.15 $8.79 -$0.33 $3.17
-减:资本性资产减值 – – $52.90M – –
少数股东权益 – – $0.00 – –
-固定资产出售收益 – – – – $0.00

资产负债表

项目 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
总资产 $32.09B $29.48B $29.44B $29.44B $29.21B
流动资产合计 $7.31B $9.19B $8.97B $8.97B $8.94B
现金及现金等价物与短期投资 $1.29B $4.28B $3.82B $3.82B $3.96B
-现金及现金等价物 $1.29B $3.38B $3.01B $3.01B $3.86B
-短期投资 $0.00 $900.00M $807.20M $807.20M $97.60M
应收款 $2.40B $1.79B $1.87B $1.87B $1.85B
-应收账款 $2.40B $1.79B $1.87B $1.87B $1.85B
存货 $2.38B $1.95B $2.17B $2.17B $2.21B
其他流动资产 $1.24B $1.17B $1.12B $1.12B $916.80M
非流动资产合计 $24.78B $20.29B $20.47B $20.47B $20.27B
固定资产净值 $3.24B $3.27B $3.32B $3.32B $3.41B
-固定资产原值 $3.24B $3.27B $6.25B $6.25B $6.27B
投资及预付款 $0.00 $465.60M $431.90M $431.90M –
商誉及其他无形资产 $20.51B $15.54B $15.67B $15.67B $15.82B
-商誉 $6.99B $6.49B $6.49B $6.49B $6.49B
-其他无形资产 $13.52B $9.05B $9.18B $9.18B $9.33B
一年以上递延资产 $202.10M $238.20M $292.50M $292.50M $312.40M
其他非流动资产 $831.80M $777.50M $750.60M $750.60M $729.70M
负债合计 $13.24B $10.83B $11.18B $11.18B $11.00B
流动负债合计 $3.92B $3.00B $3.35B $3.35B $3.29B
应付款 $490.80M $452.10M $546.80M $546.80M $516.40M
-应付账款 $403.90M $358.50M $432.00M $432.00M $413.10M
-应付税款合计 $86.90M $93.60M $114.80M $114.80M $103.30M
一年内应计费用 $2.24B $2.35B $2.43B $2.43B $2.37B
短期债务及融资租赁负债 $800.00M – – – –
-一年内到期债务 $800.00M – – – –
非流动负债合计 $9.32B $7.83B $7.83B $7.83B $7.71B
长期应付账款及其他应付款 $177.50M $174.20M – – $164.70M
长期债务及融资租赁负债 $7.56B $6.56B $6.58B $6.58B $6.59B
-长期债务 $7.29B $6.29B $6.29B $6.29B $6.29B
-长期融资租赁负债 $264.80M $273.40M $290.40M $290.40M $305.00M
一年以上递延负债 $945.50M $483.50M $507.60M $507.60M $358.10M
其他非流动负债 $643.40M $612.90M $748.50M $748.50M $597.10M
股东权益合计 $18.85B $18.65B $18.26B $18.26B $18.21B
股东权益 $18.85B $18.65B $18.26B $18.26B $18.21B
股本 $100,000.00 $100,000.00 $100,000.00 $100,000.00 $100,000.00
-普通股 $100,000.00 $100,000.00 $100,000.00 $100,000.00 $100,000.00
-优先股 $0.00 $0.00 $0.00 $0.00 $0.00
资本公积 $983.00M $896.70M $863.10M $863.10M $797.70M
留存收益 $20.97B $20.87B $20.55B $20.55B $20.60B
减:库存股 $2.98B $2.98B $2.98B $2.98B $2.98B
不影响留存收益的损益 -$127.70M -$140.20M -$182.00M -$182.00M -$214.80M
-可供出售证券 – $465.60M $431.90M $431.90M –
-累计折旧 – – -$2.93B -$2.93B -$2.87B
其他流动负债 – – – – $89.10M

现金流量表

项目 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
经营活动现金流 $448.90M $645.50M $2.20B $511.90M $1.27B
持续经营经营活动现金流净额 $448.90M $645.50M $2.20B $511.90M $1.27B
持续经营净利润 $97.50M $319.50M $1.29B -$48.90M $466.50M
持续经营损益 -$42.80M -$19.00M $19.30M -$14.40M $500,000.00
折旧、折耗与摊销 $236.10M $204.40M $779.90M $200.20M $202.20M
递延税款 -$27.60M $23.60M $361.60M $166.90M $253.80M
其他非现金项目 $346.40M $160.90M $456.90M $199.90M $100.00M
营运资金变动 -$238.10M -$127.90M -$1.06B -$108.70M $174.20M
-应收款变动 -$223.90M $69.70M $42.10M -$21.00M $229.40M
-存货变动 $75.70M $116.20M -$64.70M -$29.40M -$7.40M
-应付账款及应计费用变动 -$49.70M -$243.20M $171.10M $203.80M $286.00M
-其他营运资金变动 -$40.20M -$70.60M -$1.21B -$262.10M -$333.80M
投资活动现金流净额 -$3.84B -$209.50M -$1.37B -$1.23B -$35.10M
持续经营投资活动现金流净额 -$3.84B -$209.50M -$1.37B -$1.23B -$35.10M
固定资产购置及出售净额 -$40.90M -$51.20M -$153.80M -$43.90M -$46.20M
无形资产购置及出售净额 -$100.00M -$35.00M -$81.60M -$66.30M -$5.30M
投资购置及出售净额 $1.37B -$123.10M -$1.18B -$1.14B -$34.40M
其他投资变动净额 -$600,000.00 -$200,000.00 $42.90M $22.70M $50.80M
筹资活动现金流 $1.30B -$43.80M -$301.90M -$137.00M -$130.20M
持续经营筹资活动现金流净额 $1.30B -$43.80M -$301.90M -$137.00M -$130.20M
股票期权行使所得 $6.00M -$55.10M -$10.00M $3.00M $5.20M
其他筹资费用净额 -$13.30M $11.30M -$275.00M -$140.00M -$135.10M
期末现金余额 $1.29B $3.38B $3.01B $3.01B $3.86B
现金净变动 -$2.09B $392.20M $531.60M -$856.80M $1.11B
期初现金余额 $3.38B $3.01B $2.38B $3.86B $2.76B
汇率变动影响 -$3.40M -$18.00M $101.90M $2.50M -$3.20M
自由现金流 $308.00M $559.30M $1.97B $401.70M $1.22B
业务购买及出售净额 – – $0.00 $0.00 $0.00
债务发行及偿还净额 – – -$16.90M $0.00 -$300,000.00

讨论区

暂无评论——快来第一个聊聊 BIIB。

发表评论

Scroll to Top